Biomarkers and surrogate end points in clinical trials of tuberculosis treatment - Reply to Davies et al

Walzl, G; Mistry, R; Dockrell, HM; van Helden, PD; Cliff, JM; (2007) Biomarkers and surrogate end points in clinical trials of tuberculosis treatment - Reply to Davies et al. The Journal of infectious diseases, 196 (4). pp. 649-650. ISSN 0022-1899 DOI: https://doi.org/10.1086/519746

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1086/519746

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar